U.S. Markets open in 5 hrs 55 mins

Estimates and Recommendations for Bluebird Bio on September 6

Mike Benson
Estimates and Recommendations for Bluebird Bio on September 6

Wall Street analysts estimate that Bluebird Bio (BLUE) will report a 14.6% growth in revenues to ~$40.6 million in 2018 compared to $35.4 million in 2017. Its EPS is expected to be -$10.83 in 2018. Analysts estimate net adjusted loss of $556.6 million in 2018.